JP2020512292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020512292A5 JP2020512292A5 JP2019533167A JP2019533167A JP2020512292A5 JP 2020512292 A5 JP2020512292 A5 JP 2020512292A5 JP 2019533167 A JP2019533167 A JP 2019533167A JP 2019533167 A JP2019533167 A JP 2019533167A JP 2020512292 A5 JP2020512292 A5 JP 2020512292A5
- Authority
- JP
- Japan
- Prior art keywords
- delayed release
- linaclotide
- composition
- baseline
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022073214A JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662437566P | 2016-12-21 | 2016-12-21 | |
| US62/437,566 | 2016-12-21 | ||
| PCT/US2017/067814 WO2018119191A1 (en) | 2016-12-21 | 2017-12-21 | Methods of treating irritable bowel syndrome with modified or delayed release formulations of linaclotide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022073214A Division JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020512292A JP2020512292A (ja) | 2020-04-23 |
| JP2020512292A5 true JP2020512292A5 (https=) | 2021-02-04 |
Family
ID=61022424
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019533167A Pending JP2020512292A (ja) | 2016-12-21 | 2017-12-21 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
| JP2022073214A Pending JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022073214A Pending JP2022093472A (ja) | 2016-12-21 | 2022-04-27 | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3558337A1 (https=) |
| JP (2) | JP2020512292A (https=) |
| CN (1) | CN110475564A (https=) |
| AU (1) | AU2017379082A1 (https=) |
| BR (1) | BR112019012689A2 (https=) |
| CA (1) | CA3048195A1 (https=) |
| EA (1) | EA201991531A1 (https=) |
| MA (1) | MA47112A (https=) |
| MX (2) | MX2019007574A (https=) |
| WO (1) | WO2018119191A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220241367A1 (en) * | 2019-06-10 | 2022-08-04 | Ironwood Pharmaceutical, Inc. | Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome |
| IL313184A (en) * | 2021-11-29 | 2024-07-01 | Ironwood Pharmaceuticals Inc | Pharmaceutical compositions for the treatment of visceral pain |
| WO2023196821A2 (en) * | 2022-04-04 | 2023-10-12 | Thomas Jefferson University | Targeting neuropod cell gucy2c to control visceral pain and appetite |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7371727B2 (en) | 2003-01-28 | 2008-05-13 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| US7304036B2 (en) | 2003-01-28 | 2007-12-04 | Microbia, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CN117530912A (zh) | 2008-08-15 | 2024-02-09 | 硬木药品公司 | 适合口服给药的鸟苷酸环化酶-c受体激动剂多肽的稳定的固体制剂 |
| WO2011020054A1 (en) * | 2009-08-13 | 2011-02-17 | Ironwood Pharmaceuticals Inc. | Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists |
| US8933030B2 (en) | 2010-02-17 | 2015-01-13 | Ironwwod Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| DK2603232T3 (da) * | 2010-08-11 | 2019-12-09 | Ironwood Pharmaceuticals Inc | Stabile formuleringer af linaclotid |
| US9708371B2 (en) | 2011-08-17 | 2017-07-18 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| JP6716255B2 (ja) * | 2013-01-15 | 2020-07-01 | アイロンウッド ファーマシューティカルズ，インコーポレーテッドＩｒｏｎｗｏｏｄ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 胆汁酸捕捉剤の胃内滞留型徐放性経口剤形 |
| UA119335C2 (uk) * | 2013-12-11 | 2019-06-10 | Айронвуд Фармасьютикалз, Інк. | Композиції лінаклотиду з затриманим вивільненням |
| JP2018516937A (ja) * | 2015-06-05 | 2018-06-28 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | リナクロチドの改変または標的放出製剤 |
-
2017
- 2017-12-21 MA MA047112A patent/MA47112A/fr unknown
- 2017-12-21 EP EP17833050.2A patent/EP3558337A1/en not_active Withdrawn
- 2017-12-21 CN CN201780087073.0A patent/CN110475564A/zh active Pending
- 2017-12-21 AU AU2017379082A patent/AU2017379082A1/en not_active Abandoned
- 2017-12-21 JP JP2019533167A patent/JP2020512292A/ja active Pending
- 2017-12-21 EA EA201991531A patent/EA201991531A1/ru unknown
- 2017-12-21 BR BR112019012689-9A patent/BR112019012689A2/pt unknown
- 2017-12-21 CA CA3048195A patent/CA3048195A1/en active Pending
- 2017-12-21 WO PCT/US2017/067814 patent/WO2018119191A1/en not_active Ceased
- 2017-12-21 MX MX2019007574A patent/MX2019007574A/es unknown
-
2019
- 2019-06-21 MX MX2023008839A patent/MX2023008839A/es unknown
-
2022
- 2022-04-27 JP JP2022073214A patent/JP2022093472A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20120633T1 (hr) | Formulacija rasagilina s odgođenim oslobađanjem | |
| JP2017504590A5 (https=) | ||
| JP2020503269A5 (https=) | ||
| HRP20250615T1 (hr) | Tradipitant za upotrebu u liječenju gastropareze | |
| JP2023112076A (ja) | 経口リファマイシンｓｖ組成物 | |
| CN111698992A (zh) | 用于治疗子宫内膜异位症、子宫肌瘤、多囊卵巢综合症或子宫腺肌症的药物配制物 | |
| JP2020512292A5 (https=) | ||
| JP2020500864A5 (https=) | ||
| RU2017103511A (ru) | Способ обеспечения чувства сытости | |
| JP2024161048A (ja) | リナクロチドの改変または標的放出製剤 | |
| JP2022093472A (ja) | リナクロチドの改変放出製剤または遅延放出製剤による過敏性腸症候群の処置方法 | |
| JP2020519576A5 (https=) | ||
| CA3131645A1 (en) | Pharmaceutical oral dosage forms for treatment of metabolic disorders and related diseases through orchestrated release of enterokines | |
| US20230346878A1 (en) | Treatment of Abdominal Pain Associated with Diarrhea-Predominant Irritable Bowel Syndrome | |
| TW201420103A (zh) | 包含左炔諾孕酮（ｌｅｖｏｎｏｒｇｅｓｔｒｅｌ）及ｃｏｘ抑制劑之醫藥組合物於「依需求（ｏｎ ｄｅｍａｎｄ）」避孕之用途及應用療法 | |
| US11458104B1 (en) | Enteric coated tiopronin tablet | |
| JP2022500351A5 (https=) | ||
| RU2793319C2 (ru) | Композиции рифамицина sv для перорального применения | |
| JPWO2020251923A5 (https=) | ||
| HK40115007A (zh) | 含有局部麻醉剂的胃滞留口服剂量单元 | |
| WO2020120519A1 (en) | Combinatorial oral treatment of metabolic disorders through orchestrated release of enterokines | |
| EP4065129A1 (fr) | Utilisation de composés pour la prévention et/ou le traitement de la spondylarthrite ankylosante et compositions correspondantes | |
| RU2022106262A (ru) | Изделия и способы для введения терапевтических средств | |
| HK40017265A (en) | Methods of treating irritable bowel syndrome with modified or delayed release formulations of linaclotide | |
| JP2016515591A (ja) | 炎症性腸疾患の治療のためのピドチモドの使用 |